PriceSensitive

Dotz Nano (ASX:DTZ) secures Thailand distribution partner

ASX News, Technology
ASX:DTZ      MCAP $67.85M
08 December 2021 18:41 (AEST)

Source: Dotz Nano

Dotz Nano (DTZ) has secured its fourth distribution partner for its SARS-CoV-2 virus detection technology.

The company entered the distribution agreement with World Siam Company (WSG) in Thailand.

Effective immediately, the distribution agreement is for an initial three-year term and grants WSG the right to promote, sell and distribute the nasopharyngeal swab and saliva-based Dotz Test Kits with conditional exclusivity.

This is subject to minimum first-year purchase orders of US$250,000 (A$350,800) being met.

Dotz’s SARS-CoV-2 virus detection technology previously proved its accuracy in a blind clinical trial of the nasopharyngeal swab, Dotz Test Kits, on 73 subjects in the US.

Under the agreement, WSG may appoint sub-distributors, subject to Dotz’s approval, with the agreement automatically renewing.

 “Our distribution partners enable us to cost-effectively access and service new markets and customers,” Dotz CEO Gideon Shmuel said.

“Our latest agreement further builds our presence in Southeast Asia – a region where we see significant growth opportunities due to the genuine need for accurate, timely and cost-effective testing methods to support the tourism economy.”

While Dotz has obtained a CE Mark for both its nasopharyngeal swab and saliva-based Dotz Test Kits, which clears it for sale in the European Union, further registration is required for sales in Thailand.

WSG is currently seeking to obtain the relevant additional regulatory approvals and authorisations to clear the product for sale in Thailand, however, there is no certainty that WSG will obtain the relevant additional local regulatory approvals.

Dotz Nano was up 3.7 per cent, trading at 42 cents at market close.

Related News